
Malfree-AT Injection
Marketer
Rezicure Pharmaceuticals
Salt Composition
Artesunate (60mg)
Overview Malfree-AT Injection
Atovaquone-proguanil injection, branded as Malfree-AT, combats parasitic infections causing malaria. This injectable treatment is for malaria cases only; it's neither a preventative nor suitable for severe malaria affecting vital organs like the brain, lungs, or kidneys. Administration must be performed by a medical professional; self-injection is strictly prohibited and reserved for situations where oral medication is infeasible. Potential side effects include headache, lightheadedness, fatigue, and decreased appetite, along with localized injection site reactions such as soreness, inflammation, or discoloration. Persistent side effects warrant immediate medical attention. Post-treatment, regular blood tests (weekly for four weeks) may be conducted to monitor parasite levels.
Uses of Malfree-AT Injection
Plasmodium infection
Major Benefits of Malfree-AT Injection:
The medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Malfree-AT Injection:
- Headache
- Dizziness
- Weakness
- Loss of appetite
- Injection site reactions (pain, swelling, redness)
How to use Malfree-AT Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Malfree-AT Injection works:
Malfree-AT Injection is an anti-malarial drug that eliminates the parasite by generating cytotoxic free radicals within its cells.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Malfree-AT Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Malfree-AT Injection during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingSAFE IF PRESCRIBED
Administration of Malfree-AT Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible infant exposure.
DrivingUNSAFE
Administering Malfree-AT Injection could reduce attentiveness, impair vision, and induce drowsiness or dizziness. Driving should be avoided if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Data regarding Malfree-AT Injection's use in individuals with renal impairment is scarce. Physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Malfree-AT Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Malfree-AT Injection :
Should you forget a scheduled Malfree-AT Injection, seek advice from your physician.
Facts to Know About Malfree-AT Injection
| Label | Value |
|---|---|
| Chemical Category | Sesquiterpene lactones |
| Developing Habits | No. |
| Treatment Category | Antimalarial Medications |
| Actions | Artemisinin-based antimalarials |
